GO:0008802 betaine-aldehyde dehydrogenase (NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008802 defines the NAD+-dependent oxidation of betaine aldehyde to betaine, a critical step in glycine betaine biosynthesis and cellular osmoprotection.
• The enzyme is a member of the aldehyde dehydrogenase superfamily and typically functions as a tetramer, with NAD+ promoting assembly and catalytic activity.
• Betaine aldehyde dehydrogenase (BADH) activity is found across prokaryotes, plants, and mammals, including Escherichia coli, Staphylococcus aureus, and porcine kidney.
• The reaction consumes NAD+ and water, producing betaine, NADH, and H+, linking BADH activity to cellular redox and energy metabolism.
• BADH is regulated by potassium ions, hydrogen peroxide, and pharmacological agents such as cyclophosphamide, affecting its active-site heterogeneity and catalytic efficiency.
• Studying GO:0008802 helps elucidate mechanisms of osmotic stress adaptation, cardiac hypertrophy, and potential drug targets in infectious and metabolic diseases.
Description
Betaine-aldehyde dehydrogenase (NAD+) activity, encoded by GO:0008802, catalyzes the final step in the biosynthesis of glycine betaine, a potent osmolyte that protects cells against osmotic stress. This enzymatic activity is widely distributed from bacteria to mammals and is essential for converting betaine aldehyde to betaine using NAD+ as the electron acceptor. The reaction also produces NADH and H+, thereby influencing cellular redox balance and energy metabolism. Because glycine betaine accumulation is a key adaptive response to hyperosmotic conditions, BADH activity has attracted interest in microbiology, plant physiology, and human medicine. In mammals, BADH is highly expressed in the kidney and liver, where it contributes to osmolyte production and detoxification of reactive aldehydes. Recent studies have explored its role in cardiac hypertrophy and its modulation by drugs and ions, highlighting its physiological and pharmacological relevance. Understanding GO:0008802 at molecular, structural, and regulatory levels is therefore important for both basic research and therapeutic development.
betaine-aldehyde dehydrogenase (NAD+) activity At A Glance
| GO ID | GO:0008802 |
|---|---|
| GO term | betaine-aldehyde dehydrogenase (NAD+) activity |
| Ontology | molecular_function |
| Synonym | BADH activity, betaine aldehyde dehydrogenase activity, betaine-aldehyde:NAD+ oxidoreductase activity, betaine aldehyde oxidase activity, BetB |
| Major function | Catalyzes the NAD+-dependent oxidation of betaine aldehyde to betaine, a key osmolyte |
| Reaction | betaine aldehyde + NAD+ + H2O = betaine + NADH + H+ |
| Cofactor | NAD+ (nicotinamide adenine dinucleotide) |
| Subcellular location | Cytoplasm, mitochondria (in some organisms) |
| Pathway | Glycine betaine biosynthesis |
What Is GO:0008802?
GO:0008802 describes the catalytic activity of an enzyme that oxidizes betaine aldehyde to betaine in an NAD+-dependent manner. Specifically, it catalyzes the reaction: betaine aldehyde + NAD+ + H2O = betaine + NADH + H+. This activity is synonymous with BADH activity, betaine aldehyde dehydrogenase activity, and betaine-aldehyde:NAD+ oxidoreductase activity. The enzyme belongs to the aldehyde dehydrogenase (ALDH) superfamily and requires NAD+ as a cofactor, which is reduced to NADH during the reaction. The reaction is irreversible under physiological conditions and represents the terminal step in the choline-glycine betaine pathway in many organisms.
Why Is betaine-aldehyde dehydrogenase (NAD+) activity Important in Cell Biology?
GO:0008802 is central to the biosynthesis of glycine betaine, an osmolyte that maintains cell volume and protein stability under osmotic stress. In bacteria such as Escherichia coli and Staphylococcus aureus, BADH activity is critical for survival in hyperosmotic environments and for virulence. In mammals, BADH in the kidney and liver contributes to osmolyte balance and detoxification of aldehydes, and its dysfunction has been linked to oxidative stress and cardiac hypertrophy. Moreover, BADH is a target for drug interactions, as shown by cyclophosphamide inhibition, and its active-site heterogeneity is modulated by potassium, making it a subject of pharmacological and structural studies. Thus, understanding this activity has implications for infectious disease, metabolic disorders, and cardiovascular biology.
• Provides a key step in glycine betaine biosynthesis, essential for osmoprotection in bacteria, plants, and mammals.
• Influences cellular redox balance by consuming NAD+ and producing NADH.
• Contributes to detoxification of reactive aldehydes in kidney and liver.
• Plays a role in cardiac hypertrophy during pregnancy, as shown in animal models.
• Is a potential drug target, as its activity is modulated by cyclophosphamide and hydrogen peroxide.
• Active-site heterogeneity and potassium modulation affect catalytic efficiency and regulation.
• Structural studies of bacterial BADH inform inhibitor design for pathogens.
• NAD+ promotes assembly of active tetramers, linking cofactor availability to enzyme function.
• Relevant to metabolic engineering for osmolyte production in crops and microbes.
• Serves as a model for understanding aldehyde dehydrogenase superfamily mechanisms.
What Happens During betaine-aldehyde dehydrogenase (NAD+) activity?
Substrate Binding and Cofactor Recruitment
In simple terms: The enzyme grabs betaine aldehyde and NAD+ to start the reaction.
The catalytic cycle begins with the binding of betaine aldehyde and NAD+ to the enzyme's active site. Structural studies of Staphylococcus aureus BADH reveal a conserved Rossmann-fold domain for NAD+ binding and a catalytic cysteine residue that attacks the aldehyde. NAD+ binding also promotes the assembly of the active tetramer, as shown for aldehyde dehydrogenase 7A1, a related enzyme. In porcine kidney BADH, the enzyme exhibits heterogeneity of active sites, which is modulated by potassium ions, affecting substrate affinity.
Catalytic Oxidation and Hydride Transfer
In simple terms: The enzyme removes hydrogen from betaine aldehyde and transfers it to NAD+, forming betaine and NADH.
Following substrate binding, a nucleophilic cysteine forms a thiohemiacetal intermediate with betaine aldehyde. Hydride transfer to NAD+ yields NADH and a thioester intermediate, which is then hydrolyzed by water to release betaine and regenerate the free enzyme. This mechanism is typical of aldehyde dehydrogenases and requires a water molecule as a nucleophile. The reaction is essentially irreversible and produces NADH, linking BADH activity to cellular energy metabolism.
Product Release and Enzyme Turnover
In simple terms: The enzyme lets go of betaine and NADH so it can start over.
After hydrolysis, betaine and NADH are released from the active site, allowing the enzyme to enter another catalytic cycle. The release of NADH is often rate-limiting and can be influenced by cofactor availability. In Escherichia coli BADH, the enzyme is purified as a homotetramer and exhibits optimal activity at alkaline pH, consistent with product release requirements. Porcine kidney BADH also shows a similar turnover mechanism, with NAD+ being essential for activity.
Regulation by Ions and Redox State
In simple terms: Potassium and hydrogen peroxide can change how fast the enzyme works.
Potassium ions modulate the active-site heterogeneity of recombinant BADH, enhancing or inhibiting activity depending on concentration. Hydrogen peroxide inhibits porcine kidney BADH, likely through oxidation of catalytic cysteine residues, linking enzyme function to oxidative stress. Additionally, cyclophosphamide, an alkylating agent, affects BADH activity in porcine kidney, suggesting pharmacological regulation. These regulatory mechanisms ensure BADH activity is tuned to cellular redox and ionic conditions.
Key Genes Involved in GO:0008802 betaine-aldehyde dehydrogenase (NAD+) activity
The following genes and proteins are directly associated with betaine-aldehyde dehydrogenase (NAD+) activity across various organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| betB (E. coli) | Encodes BADH for glycine betaine synthesis | Model for osmoprotection and enzyme purification |
| badh (S. aureus) | Encodes BADH, contributes to virulence | Structural and functional studies, drug target |
| ALDH7A1 (human) | Related aldehyde dehydrogenase, NAD+ promotes tetramer assembly | Model for ALDH superfamily assembly |
| BADH (porcine kidney) | Purified enzyme, characterized for kinetics | Biochemical and inhibition studies |
| BADH (plant, e.g., spinach) | Osmoprotection in plants | Crop engineering for stress tolerance |
| betB (other bacteria) | Betaine synthesis | Comparative genomics and enzymology |
| ALDH9A1 (human) | Potential BADH activity | Metabolic and detoxification studies |
| ALDH2 (human) | Mitochondrial aldehyde dehydrogenase | Related superfamily member |
| ALDH1A1 (human) | Cytosolic aldehyde dehydrogenase | Cancer and stem cell research |
| ALDH3A1 (human) | Aldehyde dehydrogenase, corneal crystallin | Oxidative stress response |
| ALDH5A1 (human) | Succinic semialdehyde dehydrogenase | Neurotransmitter metabolism |
| ALDH6A1 (human) | Methylmalonate semialdehyde dehydrogenase | Metabolic disorders |
| ALDH7A1 (human) | Antiquitin, pipecolic acid pathway | Epilepsy and oxidative stress |
| ALDH18A1 (human) | Pyrroline-5-carboxylate synthase | Proline biosynthesis |
| GbsA (Bacillus subtilis) | Glycine betaine synthesis | Osmotolerance engineering |
| BetB (Pseudomonas) | Betaine aldehyde dehydrogenase | Biodegradation and osmoprotection |
| BADH1 (rice) | Osmoprotection in rice | Salt tolerance studies |
| BADH2 (rice) | Fragrance compound synthesis | Aroma rice breeding |
How Is betaine-aldehyde dehydrogenase (NAD+) activity Regulated?
Betaine-aldehyde dehydrogenase (NAD+) activity is regulated at multiple levels. Potassium ions modulate active-site heterogeneity and catalytic efficiency in recombinant BADH. Hydrogen peroxide inhibits the enzyme, likely via oxidation of catalytic cysteine, linking activity to cellular redox state. Cyclophosphamide, an alkylating agent, affects BADH activity in porcine kidney, suggesting pharmacological regulation. NAD+ availability promotes assembly of active tetramers, as shown for ALDH7A1, indicating cofactor-dependent regulation. Additionally, expression of BADH is upregulated during physiological cardiac hypertrophy induced by pregnancy, suggesting hormonal or physiological regulation.
betaine-aldehyde dehydrogenase (NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BADH (porcine) | Oxidative stress in kidney | Porcine kidney cell lines with H2O2 treatment |
| badh (S. aureus) | Bacterial virulence | S. aureus knockout mutants in osmotic stress |
| betB (E. coli) | Urinary tract infection | E. coli deletion strains in hyperosmotic media |
| ALDH7A1 (human) | Epilepsy, oxidative stress | Human cell lines with ALDH7A1 knockdown |
| BADH (rat) | Cardiac hypertrophy | Pregnancy-induced hypertrophy models |
Cardiac Hypertrophy and Pregnancy
Betaine aldehyde dehydrogenase expression is altered during physiological cardiac hypertrophy induced by pregnancy, suggesting a role in cardiac remodeling and osmolyte balance. The enzyme may protect cardiomyocytes from osmotic stress and oxidative damage during hypertrophic growth.
Bacterial Virulence and Osmotic Stress
In Staphylococcus aureus, BADH contributes to osmotolerance and virulence, making it a potential target for anti-infective strategies. Escherichia coli BADH is essential for survival in hyperosmotic environments, relevant to urinary tract infections.
Oxidative Stress and Kidney Injury
Porcine kidney BADH is inhibited by hydrogen peroxide, indicating that oxidative stress can impair betaine synthesis and osmoprotection in renal tissue. This links BADH dysfunction to kidney injury and metabolic stress.
Drug Interactions and Detoxification
Cyclophosphamide modulates BADH activity, suggesting that chemotherapeutic agents may interfere with osmolyte metabolism and aldehyde detoxification. This has implications for drug toxicity and patient management.
From betaine-aldehyde dehydrogenase (NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BADH protect against osmotic stress? | Knockout of betB in E. coli |
| What is the role of BADH in cardiac hypertrophy? | Knockout or overexpression in rat cardiomyocytes |
| How does potassium modulate BADH activity? | Point mutations in active-site residues |
| Can BADH be targeted for antibacterial therapy? | Knockout of badh in S. aureus |
| Does NAD+ regulate BADH assembly? | Knock-in of tagged BADH for structural studies |
| What is the effect of cyclophosphamide on BADH? | Overexpression of BADH in kidney cells |
How to Study the betaine-aldehyde dehydrogenase (NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity | Purified BADH kinetics |
| X-ray crystallography | 3D structure | Active site and cofactor binding |
| RT-qPCR | mRNA expression | Tissue-specific BADH levels |
| Western blot | Protein expression | BADH protein quantification |
| Site-directed mutagenesis | Residue function | Catalytic mechanism |
| Enzyme inhibition assays | Inhibitor effects | Drug interactions |
| Hydrogen peroxide sensitivity | Oxidative stress response | Redox regulation |
| Potassium titration | Ion modulation | Active-site heterogeneity |
Enzymatic Activity Assays
Spectrophotometric assays monitoring NADH production at 340 nm are standard for measuring BADH activity. Porcine kidney BADH was purified and characterized using such assays, revealing kinetic parameters and inhibition by hydrogen peroxide. These methods are essential for quantifying GO:0008802 activity in cell lysates or purified preparations.
Structural Biology
X-ray crystallography of Staphylococcus aureus BADH provided insights into the active site, NAD+ binding, and catalytic mechanism. Structural studies of ALDH7A1 showed how NAD+ promotes tetramer assembly, informing BADH models. These techniques are crucial for understanding molecular details of GO:0008802.
Gene Expression Analysis
RT-qPCR and Western blotting are used to measure BADH mRNA and protein levels in tissues or cells. For example, BADH expression was assessed during pregnancy-induced cardiac hypertrophy. Such methods link GO:0008802 to physiological states.
Mutagenesis and Kinetic Studies
Site-directed mutagenesis of catalytic residues, combined with kinetic analysis, identifies key amino acids for BADH activity. Heterogeneity of active sites modulated by potassium was studied using recombinant BADH mutants. This approach dissects the contribution of individual residues to GO:0008802.
How CRISPR Can Be Used to Study GO:0008802 betaine-aldehyde dehydrogenase (NAD+) activity
Knockout
CRISPR-Cas9 knockout of BADH genes (e.g., betB in E. coli or badh in S. aureus) can reveal their essentiality for osmotolerance and virulence. Knockout cell models enable phenotypic studies under hyperosmotic stress and drug treatment.
Point Mutation
Introducing point mutations in catalytic residues (e.g., cysteine) via CRISPR base editing or HDR can dissect the enzymatic mechanism of GO:0008802. Such models help validate structural predictions and kinetic data.
Knock-in
Knock-in of epitope tags or fluorescent reporters into the endogenous BADH locus allows real-time tracking of expression and localization. This is useful for studying BADH dynamics during cardiac hypertrophy or osmotic stress.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of BADH can test gain-of-function effects on osmoprotection, redox balance, and drug resistance. Overexpression models are valuable for screening inhibitors or activators.
How EDITGENE Supports betaine-aldehyde dehydrogenase (NAD+) activity Research
Researchers studying betaine-aldehyde dehydrogenase (NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in osmoprotection, metabolic regulation, or disease. EDITGENE provides comprehensive CRISPR services to generate precise cell and animal models for functional validation of GO:0008802 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for betaine-aldehyde dehydrogenase (NAD+) activity research.
Frequently Asked Questions About betaine-aldehyde dehydrogenase (NAD+) activity
What is betaine-aldehyde dehydrogenase (NAD+) activity?
It is the enzymatic activity defined by GO:0008802 that catalyzes the NAD+-dependent oxidation of betaine aldehyde to betaine, producing NADH and H+.
What genes are involved in betaine-aldehyde dehydrogenase (NAD+) activity?
Key genes include betB in E. coli, badh in S. aureus, and ALDH7A1 in humans, among others.
What is the reaction catalyzed by GO:0008802?
The reaction is: betaine aldehyde + NAD+ + H2O = betaine + NADH + H+.
Why is betaine-aldehyde dehydrogenase important for cells?
It produces glycine betaine, an osmolyte that protects cells from osmotic stress and helps maintain redox balance.
How is BADH activity regulated?
It is regulated by potassium ions, hydrogen peroxide, NAD+ availability, and pharmacological agents like cyclophosphamide.
What diseases are associated with BADH dysfunction?
Dysfunction has been linked to cardiac hypertrophy, oxidative stress in kidney, and bacterial virulence.
What model systems are used to study GO:0008802?
Common models include E. coli, S. aureus, porcine kidney cells, and rat cardiomyocytes, using knockouts, point mutants, and overexpression.
How can CRISPR be used to study BADH?
CRISPR can create knockouts, point mutations, knock-ins, and overexpression models to dissect BADH function in osmoprotection and disease.
What methods measure BADH activity?
Spectrophotometric NADH assays, X-ray crystallography, RT-qPCR, and Western blotting are commonly used.
Is BADH a potential drug target?
Yes, its role in bacterial virulence and drug interactions makes it a candidate for antimicrobial and metabolic therapies.
Conclusion
Betaine-aldehyde dehydrogenase (NAD+) activity (GO:0008802) is a fundamental enzymatic function that bridges osmoprotection, redox metabolism, and cellular stress responses. Its presence across bacteria, plants, and mammals underscores its evolutionary importance, while its regulation by ions, redox state, and drugs highlights its potential as a therapeutic target. Continued research using CRISPR models and biochemical assays will further illuminate its roles in health and disease.
References
- 1. Cruz-Valencia R et al.. 2021. Effect of the drug cyclophosphamide on the activity of porcine kidney betaine aldehyde dehydrogenase.. Mol Cell Biochem 476(3):1467-1475 PMID: 33389495
- 2. Guzman-Partida AM et al.. 1998. Porcine kidney betaine aldehyde dehydrogenase: purification and properties.. Comp Biochem Physiol B Biochem Mol Biol 119(3):485-91 PMID: 9734333
- 3. Halavaty AS et al.. 2015. Structural and functional analysis of betaine aldehyde dehydrogenase from Staphylococcus aureus.. Acta Crystallogr D Biol Crystallogr 71(Pt 5):1159-75 PMID: 25945581
- 4. Rosas-Rodríguez JA et al.. 2017. Betaine Aldehyde Dehydrogenase expression during physiological cardiac hypertrophy induced by pregnancy.. Biochem Biophys Res Commun 490(3):623-628 PMID: 28630000
- 5. Muñoz-Bacasehua C et al.. 2020. Heterogeneity of active sites in recombinant betaine aldehyde dehydrogenase is modulated by potassium.. J Mol Recognit 33(10):e2869 PMID: 32881113
- 6. Korasick DA et al.. 2018. NAD(+) promotes assembly of the active tetramer of aldehyde dehydrogenase 7A1.. FEBS Lett 592(19):3229-3238 PMID: 30184263
- 7. Rosas-Rodríguez JA et al.. 2010. Inhibition of porcine kidney betaine aldehyde dehydrogenase by hydrogen peroxide.. Redox Rep 15(6):282-7 PMID: 21208528
- 8. Falkenberg P et al.. 1990. Purification and characterization of osmoregulatory betaine aldehyde dehydrogenase of Escherichia coli.. Biochim Biophys Acta 1034(3):253-9 PMID: 2194570
